七氟醚
佐剂
谵妄
医学
荟萃分析
贝叶斯网络
重症监护医学
生物信息学
麻醉
肿瘤科
内科学
计算机科学
生物
机器学习
作者
Charles Zhang,Hong Chen,Kang Zou,Xi Qu
标识
DOI:10.3389/fphar.2025.1573640
摘要
To compare the efficacy of different anesthetic adjuvants combined with sevoflurane across specific surgical sites using a Bayesian network meta-analysis. A systematic review was conducted, following PRISMA guidelines, including 100 randomized controlled trials (RCTs) involving 8,800 pediatric patients undergoing various surgeries. The network meta-analysis evaluated 22 drug interventions, with log risk ratios (logRR) and Surface Under the Cumulative Ranking (SUCRA) probabilities calculated for each drug or combination. Among all interventions, dexmedetomidine combined with alfentanil was the most effective in reducing ED risk for tonsillectomy/adenoidectomy, achieving a SUCRA ranking of 94.63% (logRR = -2.82). For ophthalmic surgery, propofol and midazolam showed the highest efficacy (logRR = -1.83, SUCRA: 86.03%). Dexmedetomidine combined with midazolam was the optimal combination for inguinal hernia/hypospadias (logRR = -2.16, SUCRA: 81.73%) and dental/oral repairs (logRR = -1.83, SUCRA: 94.85%). For cleft lip/palate repair, dexmedetomidine alone showed significant efficacy (logRR = -1.65, SUCRA: 89.15%). In myringotomy/cochlear implantation, fentanyl was the most effective adjuvant (logRR = -1.17, SUCRA: 80.02%). Targeted use of dexmedetomidine-based combinations was found to be particularly effective across various surgeries, while fentanyl and propofol-midazolam combinations excelled in specific contexts. This study underscores the importance of tailoring anesthetic adjuvant strategies to specific surgical sites to reduce the risk of ED in pediatric patients, and provides a valuable reference for optimizing anesthetic care in this vulnerable population.
科研通智能强力驱动
Strongly Powered by AbleSci AI